Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
Biochim Biophys Acta ; 1234(1): 145-8, 1995 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-7880855

RESUMO

Recently, pIcln has been reported to be a regulator of a swelling-induced chloride conductance. We have cloned a cDNA RCL-H1 from rabbit heart, of which primary structure is highly homologous to that of pIcln. Outwardly rectifying currents were recorded in oocytes expressing RCL-H1, which is consistent with the result of pIcln. RNA blot analysis revealed the widespread expression of RCL-H1 mRNA in rabbit tissues. RCL-H1 may play an important role in regulating cell volume and give a clue to revealing molecular structure of swelling-induced chloride channel(s).


Assuntos
Canais de Cloreto/genética , Canais Iônicos , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , DNA Complementar/genética , Cães , Expressão Gênica , Dados de Sequência Molecular , Miocárdio/química , RNA Mensageiro/genética , Coelhos , Equilíbrio Hidroeletrolítico
2.
Endocrinology ; 142(5): 2005-12, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11316767

RESUMO

We have recently identified that rat organic anion transporters, polypeptide2 (oatp2) and oatp3, both of which transport thyroid hormones. However, in humans the molecular organization of the organic anion transporters has diverged, and the responsible molecule for thyroid hormone transport has not been clarified, except for human liver-specific transporter (LST-1) identified by us. In this study we isolated and characterized a novel human organic anion transporter, OATP-E from human brain. The isolated complementary DNA encodes a polypeptide of 722 amino acids with 12 transmembrane domains. A rat counterpart, oatp-E, was also identified. Homology analysis and the phylogenetic tree analysis revealed that OATP-E/oatp-E is a subfamily of the organic anion transporter. Human OATP-E transported 3,3',5-triiodo-L-thyronine (K(m), 0.9 microM), thyronine, and rT(3) in a Na(+)-independent manner. Although the clone was isolated from the brain, OATP-E messenger RNA was abundantly expressed in various peripheral tissues. The rat counterpart, oatp-E, also transported 3,3',5-triiodo-L-thyronine. In addition, in this study we revealed that human OATP, which is exclusively expressed in the brain, transported 3,3',5-triiodo-L-thyronine (K(m), 6.5 microM), T(4) (K(m), 8.0 microM), and rT(3). These data suggest that in humans, several different molecules are involved in transporting thyroid hormone: OATP in the brain, LST-1 in the liver, and OATP-E in peripheral tissues.


Assuntos
Proteínas de Transporte/isolamento & purificação , Hormônios Tireóideos/metabolismo , Sequência de Aminoácidos , Animais , Proteínas de Transporte de Ânions , Northern Blotting , Proteínas de Transporte/química , Proteínas de Transporte/fisiologia , Humanos , Dados de Sequência Molecular , Especificidade de Órgãos , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
3.
FEBS Lett ; 372(1): 20-4, 1995 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-7556635

RESUMO

We have isolated a cDNA coding for a delayed rectifier K+ channel (RBKV1.5) from rabbit heart. The amino acid sequence of RBKV1.5 displays a homology to that of other K+ channels of Kv1.5 class. Overall amino acid identity between RBKV1.5 channel and Kv1.5 channel of other species is about 85%. RNA blot analysis revealed the expression of the primary transcript in various rabbit tissues, at the highest level in both the atrium and ventricle. When expressed in Xenopus oocytes, RBKV1.5 current showed a delayed rectifier type characteristics, which was converted to rapidly inactivating currents upon coexpression with a beta subunit.


Assuntos
Miocárdio/metabolismo , Canais de Potássio de Abertura Dependente da Tensão da Membrana , Canais de Potássio/química , Canais de Potássio/fisiologia , Sequência de Aminoácidos , Animais , Encéfalo/metabolismo , Clonagem Molecular , Canais de Potássio de Retificação Tardia , Rim/metabolismo , Pulmão/metabolismo , Potenciais da Membrana , Dados de Sequência Molecular , Oócitos , Técnicas de Patch-Clamp , Canais de Potássio/genética , RNA Mensageiro/análise , RNA Mensageiro/genética , Coelhos , Ratos , Xenopus
4.
Br J Pharmacol ; 116(3): 2062-6, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8640346

RESUMO

1. In the present study we estimated the KA value of endothelin-1 (ET-1) for ETA-receptors by a new method in which the level of expression of ETA-receptors in Xenopus oocytes was altered in a controlled way. 2. Kvl.2 (a delayed rectifier type K channel) c RNA at the fixed concentration of 0.2 micro g micro l(-1) was mixed with ETA-receptor cRNA at various concentration ratios (10(-3)-3). Oocytes were examined 2-4 days after the injection of the cRNA mixtures. 3. In these oocytes, ET-1 suppressed the amplitude of Kvl.2 current in a dose-dependent manner in the range of 0.1-100 nM; the maximum inhibition produced by ET-1 was larger and the EC50 value for the inhibition by ET-1 was smaller as the mixture ratio was increased. Double-reciprocal plots of equiactive concentrations of ET-1 in 1/1- and 1/30-injected oocytes yielded a KA for ET-1 of 7.4 nM. The number of ETA-receptors in 1/30-injected oocytes was 13% of that in 1/1-injected oocytes, whereas the inhibition of the current in 1/30-injected oocytes was about 60% of that in 1/1-injected oocytes. This suggests the presence of spare receptors of ETA in the latter. 4. A saturation binding experiment estimated a KD value of 0.1 nM for ET-1 at ETA-receptors and the number of ETA-receptors in 1/30-injected oocytes was 23% of that in 1/1-injected ones. This value was not significantly different from that estimated by the above new method. However, there was a discrepancy between KA and KD, which could be due to factors unique to the expression system employed in the present study.


Assuntos
Endotelinas/metabolismo , Oócitos/metabolismo , Receptores de Endotelina/metabolismo , Análise de Variância , Animais , Ligação Competitiva , Relação Dose-Resposta a Droga , Feminino , Oócitos/citologia , Técnicas de Patch-Clamp , RNA Complementar/genética , RNA Complementar/metabolismo , Receptor de Endotelina A , Xenopus laevis
5.
Biochem Pharmacol ; 37(18): 3377-81, 1988 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-2844186

RESUMO

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), a new compound synthesized from dihydropyridine, was examined for its effect on calmodulin (CaM) function. The concentration of CV-159 producing 50% inhibition of Ca2+/CaM activated myosin light chain kinase (MLC kinase) was 6.2 microM. The apparent Ki value of CV-159 was 0.8 microM for MLC kinase. On the other hand, the concentration of CV-159 producing 50% inhibition of Ca2+/CaM activated cyclic nucleotide phosphodiesterase (Ca2+-PDE) was 0.55 microM. CaM antagonized competitively the CV-159-induced inhibition of activation of both MLC kinase and Ca2+-PDE. Interaction of CV-159 with CaM was also demonstrated by fluorescence studies using dansyl-CaM (5-dimethylaminonaphthalene-1-sulfonylated CaM). CV-159 produced a decrease in fluorescence intensity of dansyl-CaM, in a Ca2+-dependent fashion, and the concentration of this drug producing 50% inhibition of dansyl-CaM fluorescence was 1.2 microM. However, the concentration of nicardipine producing 50% inhibition of MLC kinase exceeded 100 microM. CaM did not antagonize the nicardipine-induced inhibition of Ca2+-PDE. These results suggest that the action of CV-159 is unique in that it inhibits both Ca2+-PDE and MLC kinase, through interaction with calmodulin. CV-159 seems to be a different class of drug from known dihydropyridine compounds.


Assuntos
Calmodulina/antagonistas & inibidores , Di-Hidropiridinas/farmacologia , 2',3'-Nucleotídeo Cíclico Fosfodiesterases/antagonistas & inibidores , Animais , Cálcio/farmacologia , Bovinos , Compostos de Dansil , Quinase de Cadeia Leve de Miosina/antagonistas & inibidores , Nicardipino/farmacologia
6.
Biochem Pharmacol ; 37(15): 2987-92, 1988 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-3164998

RESUMO

The inhibitory potencies of bioflavonoids on various tyrosine protein kinases and serine/threonine protein kinases were investigated. The phosphotransferase activity of an oncogene product, pp130fps, and a growth factor receptor, insulin receptor, were inhibited by myricetin, a derivative of quercetin. However, tyrosine kinase activity in the particulate fraction from human platelets (PM-TPK) was resistant to myricetin. Apparent Ki values of myricetin for tyrosine protein kinases of pp130fps and insulin receptor were 1.8 and 2.6 microM, respectively. The Ki values for serine/threonine kinase activities of myosin light chain kinase (MLC-kinase), casein kinase I, casein kinase II, cAMP-dependent protein kinase, and protein kinase C were 1.7 microM, 9.0 microM, 0.6 microM, 27.5 microM, and 12.1 microM, respectively. Lineweaver-Burk plots revealed that myricetin competitively inhibits pp130fps tyrosine kinase, myosin light chain kinase, casein kinase I and II with ATP, but does not inhibit other protein kinases. Since myricetin is a hydroxylated derivative of quercetin, the inhibitory effects of a series of seven flavonoids with various numbers of hydroxy residues were examined. Structure activity studies exhibited that the inhibitory potencies of the flavonoids for tyrosine kinases of pp130fps and insulin receptor correlated with the number of hydroxy residues on the flavone rings (gamma = 0.974 and 0.926, respectively), whereas the hydroxylation influenced to a lesser extent the inhibitory potencies for serine/threonine protein kinase. The hydroxy residues at position 3' and 5' did not affect the activities of cAMP-dependent protein kinase, and protein kinase C, and the hydroxylation at position 5' is detrimental for the inhibition of MLC-kinase, and casein kinase I and II. Thus, flavonoids may be useful tools to elucidate the active site of tyrosine and serine/threonine protein kinases.


Assuntos
Flavonoides/farmacologia , Proteínas Tirosina Quinases/antagonistas & inibidores , Animais , Plaquetas/enzimologia , Caseína Quinases , Humanos , Quinase de Cadeia Leve de Miosina/antagonistas & inibidores , Quinase de Cadeia Leve de Miosina/metabolismo , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Inibidores de Proteínas Quinases , Proteínas Quinases/metabolismo , Proteínas Tirosina Quinases/metabolismo , Receptor de Insulina/efeitos dos fármacos , Receptor de Insulina/metabolismo , Relação Estrutura-Atividade
7.
Eur J Pharmacol ; 268(3): 451-4, 1994 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-7805772

RESUMO

To investigate mechanisms for the receptor-mediated inhibition of a rat cardiac K+ channel clone (KV1.2), we coexpressed KV1.2 with a subtype of endothelin receptors (ETA) in Xenopus oocytes. Effects of endothelin ETA receptor stimulation were mimicked by application of PMA (4-beta-phorbol 12-myristate 13-acetate; 0.1 microM) or intracellular injection of CaCl2 (estimated concentration of 1 microM). These effects diminished in the presence of staurosporine (1 microM) or EGTA (estimated concentration of 5 mM). These results suggest that both activation of protein kinase C and an increase in intracellular Ca2+ contribute to the suppression.


Assuntos
Canais de Potássio/metabolismo , Receptores de Endotelina/metabolismo , Alcaloides/farmacologia , Animais , Cálcio/metabolismo , Miocárdio/metabolismo , Oócitos/metabolismo , Técnicas de Patch-Clamp , Fosfatidilinositóis/metabolismo , Plasmídeos/fisiologia , Canais de Potássio/efeitos dos fármacos , Proteína Quinase C/antagonistas & inibidores , RNA Complementar/biossíntese , Ratos , Receptores de Endotelina/genética , Sistemas do Segundo Mensageiro/fisiologia , Estaurosporina , Acetato de Tetradecanoilforbol/farmacologia , Xenopus
8.
Neurosci Lett ; 118(1): 41-4, 1990 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-2259465

RESUMO

Histamine H1 receptors were visualized in the living dog brain using [11C]pyrilamine or [11C]doxepin by positron emission tomography (PET). The regional distribution of these carbon-11 labeled compounds in the brain corresponded well with that of the histamine H1 receptors separately determined by in vitro binding assay. The radioactivity in the brain was reduced by treatment with triprolidine (1 mg/kg), a histamine H1 antagonist. The results of our study indicate that it is feasible to visualize histamine H1 receptors in human brain using these 11C-labeled compounds and PET.


Assuntos
Encéfalo/diagnóstico por imagem , Receptores Histamínicos H1/metabolismo , Animais , Encéfalo/metabolismo , Cães , Doxepina/metabolismo , Pirilamina/metabolismo , Tomografia Computadorizada de Emissão , Triprolidina/farmacologia
9.
Naunyn Schmiedebergs Arch Pharmacol ; 321(3): 185-9, 1982 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7155197

RESUMO

The role of the posterior hypothalamus in the baroreceptor reflex was investigated in dogs. The posterior hypothalamus was superfused bilaterally through push-pull cannulae with artificial cerebrospinal fluid. After bilateral superfusion with tetrodotoxin (10(-5) M) for 120 min, the increases in mean arterial pressure and heart rate induced by the electrical stimulation of the posterior hypothalamus were almost abolished, and the resting mean arterial pressure was significantly decreased. Under these circumstances the increases in mean arterial pressure and heart rate in response to bilateral carotid occlusion were significantly reduced. The decrease in mean arterial pressure induced by intravenous injection of sodium nitroprusside (5 micrograms/kg) was significantly augmented while the associated increase in heart rate was suppressed. These results suggest that the posterior hypothalamus plays an important role in maintaining the resting arterial pressure and in the baroreceptor reflex to increase the arterial pressure and heart rate.


Assuntos
Hipotálamo Posterior/efeitos dos fármacos , Hipotálamo/efeitos dos fármacos , Pressorreceptores/efeitos dos fármacos , Reflexo/efeitos dos fármacos , Tetrodotoxina/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Cães , Estimulação Elétrica , Frequência Cardíaca/efeitos dos fármacos , Nitroprussiato/farmacologia
12.
Tohoku J Exp Med ; 137(1): 59-63, 1982 May.
Artigo em Inglês | MEDLINE | ID: mdl-6954732

RESUMO

To test the possibility that prostaglandin F2 alpha and histamine might produce salivary and vasodilator responses by stimulation of preganglionic parasympathetic nerve fibers in the submandibular gland the responses to the two substances of chronically decentralized glands were compared with those of acutely decentralized ones in anesthetized dogs. No significant differences in responses to either prostaglandin F2 alpha or histamine were noted between chronically decentralized glands and acutely decentralized ones. Thus, it was concluded that prostaglandin F2 alpha and histamine only stimulate parasympathetic postganglionic neurons within the gland and neither of the responses is related to non-cholinergic ganglionic transmission.


Assuntos
Gânglios Parassimpáticos/fisiologia , Histamina/farmacologia , Prostaglandinas F/farmacologia , Glândula Submandibular/inervação , Acetilcolina/farmacologia , Animais , Dinoprosta , Cães , Nicotina/farmacologia , Glândula Submandibular/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos
13.
Tohoku J Exp Med ; 134(1): 1-8, 1981 May.
Artigo em Inglês | MEDLINE | ID: mdl-6458925

RESUMO

The submandibular gland in situ was perfused with blood through the glandular artery at constant pressure in anesthetized dogs, and all drugs were administered intra-arterially. During infusion of metiamide, histamine and 2-(2-pyridyl)ethylamine (PEA) produced salivary and vasodilator responses consisting of an early and a late component. The dose-response curves for respective components of the salivary and vasodilator responses to PEA were parallel with the corresponding curves for histamine and in producing these responses PEA was about 40 times less potent than histamine on a molar basis. During infusion of mepyramine, histamine and dimaprit produced only the early vasodilator response. The dose-vasodilator response curves to histamine and dimaprit were parallel, and dimaprit was about 750 times less potent than histamine on a molar basis. The present results support the conclusion obtained in a previous study that neuronal histamine receptors mediating the whole salivary and the late vasodilator response are exclusively of the H1-type and vascular histamine receptors mediating the early vasodilator response consist of both H1-and H2-type although the former is predominant.


Assuntos
Histamina/farmacologia , Receptores Histamínicos/fisiologia , Glândula Submandibular/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos , Animais , Dimaprit , Cães , Feminino , Masculino , Piridinas/farmacologia , Fluxo Sanguíneo Regional/efeitos dos fármacos , Salivação/efeitos dos fármacos , Glândula Submandibular/irrigação sanguínea , Tioureia/farmacologia
14.
Biochem Biophys Res Commun ; 184(3): 1484-9, 1992 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-1590805

RESUMO

We have cloned a delayed rectifier type K channel from rat heart (RH1). RH1 was identical to the rat brain K channel BK2 and differed from recently cloned rat cardiac K channel RAK by one amino acid residue. Endothelin receptors(ETRs)-mediated modulation of RH1 current (IRH1) was studied using Xenopus oocyte expression system. Activation of two different subtypes of ETRs by endothelin-1 equally suppressed the amplitude of IRH1. Stimulation of phosphatidylinositol turnover will probably be responsible for the suppression.


Assuntos
Endotelinas/farmacologia , Coração/fisiologia , Canais de Potássio/genética , Canais de Potássio/fisiologia , Animais , Clonagem Molecular , DNA/genética , Potenciais Evocados/efeitos dos fármacos , Feminino , Vetores Genéticos , Masculino , Potenciais da Membrana/efeitos dos fármacos , Oócitos/efeitos dos fármacos , Oócitos/fisiologia , Fosfatidilinositóis/metabolismo , Canais de Potássio/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Proteínas Recombinantes/efeitos dos fármacos , Proteínas Recombinantes/metabolismo , Tetraetilamônio , Compostos de Tetraetilamônio/farmacologia , Xenopus laevis
15.
Jpn Heart J ; 26(6): 1011-8, 1985 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2937939

RESUMO

The efficacies of MDL 17043 and MDL 19205 in ameliorating heart failure were assessed in dog heart-lung preparations in which cardiac function had been severely depressed by pentobarbital. Six preparations were used for each drug. Both drugs in doses of 1-30 mumol similarly improved cardiac function in a dose-dependent manner and at 30 mumol improved it beyond control values. AV conduction impaired by pentobarbital was restored by 30 mumol of the 2 drugs. In these doses, however, neither of the drugs produced a significant increase in heart rate or arrhythmias. These results indicate that the 2 drugs would be of use in the treatment of heart failure.


Assuntos
Cardiotônicos/uso terapêutico , Insuficiência Cardíaca/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Imidazóis/uso terapêutico , Animais , Pressão Sanguínea/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Cães , Relação Dose-Resposta a Droga , Enoximona , Feminino , Sistema de Condução Cardíaco/efeitos dos fármacos , Insuficiência Cardíaca/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Imidazóis/farmacologia , Masculino
16.
J Cardiovasc Pharmacol ; 7(3): 508-15, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-2410682

RESUMO

The mechanism of the vasodilator action of bunitrolol was investigated in pentobarbital-anesthetized dogs. When injected intraarterially, bunitrolol increased blood flow through the femoral arterial bed more effectively than that through the vascular bed of the left anterior descending coronary artery (LAD). The former is rich in alpha-adrenoceptors and tonically controlled by the sympathetic nerves, whereas the latter is not. Intraarterial prazosin increased femoral flow but not LAD flow, whereas intraarterial nitrendipine increased equieffectively both femoral and LAD flows. In the saphenous arterial bed of dogs that also underwent spinal anesthesia and received atropine and nadolol, intravenous bunitrolol suppressed more effectively vasoconstrictor responses to saphenous nerve stimulation than those to intraarterial norepinephrine. These effects of bunitrolol were similar to those of prazosin and dissimilar to those of yohimbine. In similarly treated dogs, bunitrolol suppressed more effectively increases in mean systemic arterial pressure in response to methoxamine than those to B-HT 920. From these results, it was concluded that an alpha 1-adrenoceptor blocking action is mainly involved in the acute vasodilator effect of bunitrolol. This action may also contribute to the decrease in total peripheral resistance seen in hypertensive patients treated chronically with bunitrolol.


Assuntos
Propanolaminas/farmacologia , Receptores Adrenérgicos alfa/metabolismo , Vasodilatação/efeitos dos fármacos , Raquianestesia , Animais , Atropina/farmacologia , Azepinas/farmacologia , Vasos Coronários/efeitos dos fármacos , Cães , Relação Dose-Resposta a Droga , Estimulação Elétrica , Extremidades/inervação , Feminino , Artéria Femoral/efeitos dos fármacos , Injeções Intra-Arteriais , Masculino , Metoxamina/farmacologia , Nadolol , Nifedipino/análogos & derivados , Nifedipino/farmacologia , Nitrendipino , Norepinefrina/administração & dosagem , Norepinefrina/farmacologia , Prazosina/farmacologia , Vasoconstrição/efeitos dos fármacos , Ioimbina/farmacologia
17.
Proc Natl Acad Sci U S A ; 86(17): 6816-20, 1989 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2549550

RESUMO

Purified dihydropyridine-sensitive calcium channels from rabbit skeletal muscle were reconstituted into phosphatidylcholine vesicles to evaluate the effect of phosphorylation by cyclic AMP-dependent protein kinase (PK-A) on their function. Both the rate and extent of 45Ca2+ uptake into vesicles containing reconstituted calcium channels were increased severalfold after incubation with ATP and PK-A. The degree of stimulation of 45Ca2+ uptake was linearly proportional to the extent of phosphorylation of the alpha 1 and beta subunits of the calcium channel up to a stoichiometry of approximately 1 mol of phosphate incorporated into each subunit. The calcium channels activated by phosphorylation were determined to be incorporated into the reconstituted vesicles in the inside-out orientation and were completely inhibited by low concentrations of dihydropyridines, phenylalkylamines, Cd2+, Ni2+, and Mg2+. The results demonstrate a direct relationship between PK-A-catalyzed phosphorylation of the alpha 1 and beta subunits of the purified calcium channel and activation of the ion conductance activity of the dihydropyridine-sensitive calcium channels.


Assuntos
Canais de Cálcio/fisiologia , Músculos/fisiologia , Trifosfato de Adenosina/metabolismo , Animais , Cálcio/metabolismo , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/efeitos dos fármacos , Canais de Cálcio/ultraestrutura , Radioisótopos de Cálcio , Cátions Bivalentes , Fracionamento Celular , Cinética , Proteínas de Membrana/metabolismo , Fosfatidilcolinas , Radioisótopos de Fósforo , Fosforilação , Coelhos
18.
Heart Vessels ; 1(4): 216-9, 1985 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3831029

RESUMO

The efficacy of denopamine, an orally active beta 1-adrenoceptor agonist, in improving cardiac failure was assessed in dog heart-lung preparations. Cardiac functions depressed by pentobarbital (118 +/- 28 mg; mean value +/- SD) such that cardiac output and maximum rate of rise of left ventricular pressure (LV dP/dt max) had been reduced by about 35% and 26% of the respective controls were improved by denopamine (10-300 micrograms) in a dose-dependent manner. With 100 micrograms denopamine, almost complete restoration of cardiac performance was attained, associated with a slight increase in heart rate. No arrhythmias were induced by these doses of denopamine. The results warrant clinical trials of denopamine in the treatment of cardiac failure.


Assuntos
Cardiotônicos/farmacologia , Etanolaminas/farmacologia , Cardiopatias/tratamento farmacológico , Hemodinâmica/efeitos dos fármacos , Animais , Pressão Sanguínea/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Cardiotônicos/antagonistas & inibidores , Cardiotônicos/uso terapêutico , Cães , Etanolaminas/antagonistas & inibidores , Etanolaminas/uso terapêutico , Feminino , Átrios do Coração/efeitos dos fármacos , Sistema de Condução Cardíaco/efeitos dos fármacos , Cardiopatias/induzido quimicamente , Cardiopatias/fisiopatologia , Frequência Cardíaca/efeitos dos fármacos , Masculino , Pentobarbital , Propranolol/farmacologia
19.
Tohoku J Exp Med ; 192(3): 181-93, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11249148

RESUMO

The selectivities, potencies and efficacies of beta3-adrenoceptor (beta3-AR) agonists on human three beta-AR subtypes expressed in Chinese hamster ovary (CHO) cells were investigated using radioligand binding assay and cyclic AMP (cAMP) accumulation assay. The three beta-AR subtypes showed the nature of G protein-coupled receptors with the constitutive activity. BRL37344, CL-316,243 and a newly synthesized beta3-AR agonist N-5984, 6-[2-(R)-[[2-(R)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid, were compared for the potency and selectivity for the beta3-AR. In the radioligand binding assay, the affinity of N-5984 for beta3-ARs was 14, 70 and 220 times more potent than those of BRL37344, isoproterenol and CL-316,243, respectively. N-5984 had higher selectivity than BRL37344 for human beta3-ARs compared with either for beta1-ARs or beta2-ARs. N-5984 showed higher potency and intrinsic activity of cAMP production than BRL37344 in CHO cells expressing the beta3-ARs. CL-316,243 had almost no activity of cAMP production in CHO cells expressing any subtype of beta-ARs. These results indicate that N-5984 is the most potent and selective agonist for human beta3-ARs than any other agonists tested.


Assuntos
Agonistas Adrenérgicos beta/farmacologia , Ácidos Carboxílicos/farmacologia , Dioxinas/farmacologia , Dioxóis/farmacologia , Etanolaminas/farmacologia , Receptores Adrenérgicos beta/metabolismo , Animais , Células CHO , Clonagem Molecular , Cricetinae , AMP Cíclico/metabolismo , Relação Dose-Resposta a Droga , Humanos , Isoproterenol/farmacologia , Estrutura Molecular , Isoformas de Proteínas/metabolismo , Ensaio Radioligante , Receptores Adrenérgicos beta/química , Proteínas Recombinantes/metabolismo
20.
J Pharmacol Exp Ther ; 296(2): 405-11, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11160624

RESUMO

We studied the effects of acidic pH on the currents through voltage-gated K+ channels, Kv1.2, Kv1.4, and their tandem construct (Kv1.4-Kv1.2). Kv1.4 currents were inhibited considerably under acidic pH in a voltage-independent manner, whereas Kv1.2 currents were less inhibited in an apparently voltage-dependent manner. The apparent voltage-dependent block of Kv1.2 currents was mostly ascribed to the shift of activation voltage, which is probably due to surface charge effects of H+ ions. Mutagenesis analysis identified the histidine residue at 508 (H508) in the S5-H5 linker as a molecular determinant of pH sensitivity of Kv1.4. Currents through the tandem channel showed intermediate characteristics between the two parent channels in both sensitivity and voltage dependence of pH effects. Our results suggest that 1) the H508 plays a critical role in determining pH sensitivity of Kv1.4; and 2) the two parent channels, Kv1.2 and Kv1.4, are involved in determining pH sensitivity and apparent voltage dependence of the tandem channel.


Assuntos
Histidina/fisiologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana , Canais de Potássio/metabolismo , Sequência de Aminoácidos , Eletrofisiologia , Histidina/genética , Concentração de Íons de Hidrogênio , Canal de Potássio Kv1.2 , Canal de Potássio Kv1.4 , Dados de Sequência Molecular , Mutagênese , Canais de Potássio/genética , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA